Redmile Group’s Zimmer Biomet ZBH Stock Holding History

Redmile Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-151,372	Closed	-$22M	–	76
2023 Q2	$22M	Buy	+151,372	New	+$20.6M	0.85%	34
2014 Q3	–	Sell	-263,735	Closed	-$26.6M	–	65
2014 Q2	$26.6M	Buy	+263,735	New	+$25.7M	3.23%	12
2014 Q1	–	Sell	-378,669	Closed	-$34.3M	–	67
2013 Q4	$34.3M	Buy	+378,669	New	+$32.8M	4.23%	3
2013 Q3	–	Sell	-183,237	Closed	-$13.3M	–	60
2013 Q2	$13.3M	Buy	+183,237	New	+$13.7M	2.35%	17

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Redmile Group's ZBH Position: Q3 2023 in Review

Redmile Group sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 151,372 shares — an estimated $22M sold.

Redmile Group first reported a position in ZBH in Q2 2013 and held it in 4 quarters. The position peaked at $34.3M in Q4 2013. 1,015 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Redmile Group reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Redmile Group sold 151,372 Zimmer Biomet shares in Q3 2023, an estimated $22M.
Redmile Group first reported a position in Zimmer Biomet in Q2 2013 and held it in 4 quarters.
Redmile Group's Zimmer Biomet position peaked at $34.3M in Q4 2013.
1,015 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Redmile Group's 13F filing for Q3 2023, filed 14 Nov 2023.